Brief: Aslan Pharmaceuticals ADSs Debut about 14 pct below IPO price
04/05/2018 20:19
May 4 (Reuters) -
* ASLAN PHARMACEUTICALS ADSS OPEN AT $6.15 IN DEBUT ON THE
NASDAQ
VERSUS IPO PRICE OF $7.03/ADS
Further company coverage: ASLN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln